Logo image of ATEME.PA

ATEME SA (ATEME.PA) Stock Fundamental Analysis

EPA:ATEME - FR0011992700 - Common Stock

6.06 EUR
+0.06 (+1%)
Last: 9/4/2025, 10:49:24 AM
Fundamental Rating

3

Overall ATEME gets a fundamental rating of 3 out of 10. We evaluated ATEME against 26 industry peers in the Communications Equipment industry. ATEME has a bad profitability rating. Also its financial health evaluation is rather negative. ATEME is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ATEME had negative earnings in the past year.
ATEME had a positive operating cash flow in the past year.
ATEME had negative earnings in 4 of the past 5 years.
In multiple years ATEME reported negative operating cash flow during the last 5 years.
ATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFATEME.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M -6M

1.2 Ratios

ATEME's Return On Assets of -4.54% is in line compared to the rest of the industry. ATEME outperforms 53.85% of its industry peers.
ATEME has a Return On Equity (-16.00%) which is in line with its industry peers.
Industry RankSector Rank
ROA -4.54%
ROE -16%
ROIC N/A
ROA(3y)-2.76%
ROA(5y)-1.47%
ROE(3y)-8.87%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ATEME.PA Yearly ROA, ROE, ROICATEME.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

ATEME's Gross Margin of 57.97% is fine compared to the rest of the industry. ATEME outperforms 69.23% of its industry peers.
ATEME's Gross Margin has been stable in the last couple of years.
ATEME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.28%
GM growth 5Y1.27%
ATEME.PA Yearly Profit, Operating, Gross MarginsATEME.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

ATEME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATEME has been increased compared to 1 year ago.
Compared to 5 years ago, ATEME has more shares outstanding
The debt/assets ratio for ATEME has been reduced compared to a year ago.
ATEME.PA Yearly Shares OutstandingATEME.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ATEME.PA Yearly Total Debt VS Total AssetsATEME.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.51, we must say that ATEME is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.51, ATEME perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
ATEME has a debt to FCF ratio of 17.15. This is a negative value and a sign of low solvency as ATEME would need 17.15 years to pay back of all of its debts.
With a Debt to FCF ratio value of 17.15, ATEME is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
ATEME has a Debt/Equity ratio of 0.74. This is a neutral value indicating ATEME is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.74, ATEME is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 17.15
Altman-Z 1.51
ROIC/WACCN/A
WACC5.72%
ATEME.PA Yearly LT Debt VS Equity VS FCFATEME.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

ATEME has a Current Ratio of 1.49. This is a normal value and indicates that ATEME is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ATEME (1.49) is comparable to the rest of the industry.
ATEME has a Quick Ratio of 1.37. This is a normal value and indicates that ATEME is financially healthy and should not expect problems in meeting its short term obligations.
ATEME has a better Quick ratio (1.37) than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.37
ATEME.PA Yearly Current Assets VS Current LiabilitesATEME.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

ATEME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.46%.
ATEME shows a decrease in Revenue. In the last year, the revenue decreased by -6.53%.
The Revenue has been growing slightly by 7.11% on average over the past years.
EPS 1Y (TTM)-33.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%527.35%
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y5.87%
Revenue growth 5Y7.11%
Sales Q2Q%3.55%

3.2 Future

The Earnings Per Share is expected to grow by 56.77% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.06% on average over the next years. This is quite good.
EPS Next Y146.79%
EPS Next 2Y77.13%
EPS Next 3Y56.77%
EPS Next 5YN/A
Revenue Next Year6.67%
Revenue Next 2Y7.8%
Revenue Next 3Y8.06%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ATEME.PA Yearly Revenue VS EstimatesATEME.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ATEME.PA Yearly EPS VS EstimatesATEME.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEME. In the last year negative earnings were reported.
ATEME is valuated rather expensively with a Price/Forward Earnings ratio of 23.07.
ATEME's Price/Forward Earnings ratio is in line with the industry average.
ATEME's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.48.
Industry RankSector Rank
PE N/A
Fwd PE 23.07
ATEME.PA Price Earnings VS Forward Price EarningsATEME.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

ATEME's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ATEME is more expensive than 69.23% of the companies in the same industry.
ATEME's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 32.7
EV/EBITDA 361.54
ATEME.PA Per share dataATEME.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

ATEME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ATEME's earnings are expected to grow with 56.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.13%
EPS Next 3Y56.77%

0

5. Dividend

5.1 Amount

ATEME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ATEME SA

EPA:ATEME (9/4/2025, 10:49:24 AM)

6.06

+0.06 (+1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)04-24 2025-04-24
Earnings (Next)09-25 2025-09-25
Inst Owners22.34%
Inst Owner ChangeN/A
Ins Owners25.61%
Ins Owner ChangeN/A
Market Cap70.24M
Analysts86
Price Target7.65 (26.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.92%
EPS NY rev (3m)-1.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.07
P/S 0.75
P/FCF 32.7
P/OCF 17.95
P/B 2.09
P/tB 8.2
EV/EBITDA 361.54
EPS(TTM)-0.47
EYN/A
EPS(NY)0.26
Fwd EY4.33%
FCF(TTM)0.19
FCFY3.06%
OCF(TTM)0.34
OCFY5.57%
SpS8.07
BVpS2.9
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.54%
ROE -16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.97%
FCFM 2.3%
ROA(3y)-2.76%
ROA(5y)-1.47%
ROE(3y)-8.87%
ROE(5y)-4.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.28%
GM growth 5Y1.27%
F-Score3
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 17.15
Debt/EBITDA 92.65
Cap/Depr 42.02%
Cap/Sales 1.89%
Interest Coverage N/A
Cash Conversion 1459.7%
Profit Quality N/A
Current Ratio 1.49
Quick Ratio 1.37
Altman-Z 1.51
F-Score3
WACC5.72%
ROIC/WACCN/A
Cap/Depr(3y)51.6%
Cap/Depr(5y)53.6%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%527.35%
EPS Next Y146.79%
EPS Next 2Y77.13%
EPS Next 3Y56.77%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.53%
Revenue growth 3Y5.87%
Revenue growth 5Y7.11%
Sales Q2Q%3.55%
Revenue Next Year6.67%
Revenue Next 2Y7.8%
Revenue Next 3Y8.06%
Revenue Next 5YN/A
EBIT growth 1Y-63.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year296.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y236.99%
FCF growth 3YN/A
FCF growth 5Y-12.09%
OCF growth 1Y522.93%
OCF growth 3YN/A
OCF growth 5Y-6.11%